首页> 外文期刊>PLOS Neglected Tropical Diseases >Antigenicity and Diagnostic Potential of Vaccine Candidates in Human Chagas Disease
【24h】

Antigenicity and Diagnostic Potential of Vaccine Candidates in Human Chagas Disease

机译:人类恰加斯病疫苗候选者的抗原性和诊断潜力

获取原文
           

摘要

Background Chagas disease, caused by Trypanosoma cruzi, is endemic in Latin America and an emerging infectious disease in the US and Europe. We have shown TcG1, TcG2, and TcG4 antigens elicit protective immunity to T. cruzi in mice and dogs. Herein, we investigated antigenicity of the recombinant proteins in humans to determine their potential utility for the development of next generation diagnostics for screening of T. cruzi infection and Chagas disease.
机译:背景由锥虫锥虫引起的南美锥虫病在拉丁美洲很流行,在美国和欧洲正在成为一种新兴的传染病。我们已经显示,TcG1,TcG2和TcG4抗原在小鼠和狗中引起对克氏锥虫的保护性免疫。在这里,我们调查了人类中重组蛋白的抗原性,以确定其潜在潜力,可用于开发用于筛查克氏锥虫感染和南美锥虫病的下一代诊断方法。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号